Multidisciplinary approach to treatment with immune checkpoint inhibitors in patients with HIV, tuberculosis, or underlying autoimmune diseases

We reviewed the available information on the use of immune checkpoint inhibitors (ICIs) in populations with special conditions, namely, patients with HIV, tuberculosis, or underlying autoimmune disease. Available data show that treatment with ICIs is safe in patients with HIV; it is advisable, howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguilar-Company, Juan, Lopez-Olivo, Maria A., Ruiz-Camps, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334667/
https://www.ncbi.nlm.nih.gov/pubmed/35911382
http://dx.doi.org/10.3389/fmed.2022.875910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334667/
https://www.ncbi.nlm.nih.gov/pubmed/35911382
http://dx.doi.org/10.3389/fmed.2022.875910

Ejemplares similares